InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Zumwalt Leanne M, 董事. Officer active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 4 disclosures have been published. Activity tracked since 8 June 2022. The latest transaction was disclosed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Leanne M. Zumwalt is a Director at Akebia Therapeutics, Inc. She contributes to corporate governance and the strategic direction of the company. As a board member, she participates in important decision-making and oversight of Akebia's operations. Her experience in the biopharmaceutical sector is an asset for the company.